Preclinical leads for chemoprevention of colorectal cancer: novel strategies to regulate apoptosis and proliferation
PhD ceremony: Ms. D.M. Heijink, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen
Title: Preclinical leads for chemoprevention of colorectal cancer: novel strategies to regulate apoptosis and proliferation
Promotor(s): prof. E.G.E. de Vries, prof. J.H. Kleibeuker
Faculty: Medical Sciences
Colorectal cancer is potentially preventable because it develops relatively slow via the premalignant stage of an adenoma. Prevention is especially worthwhile for individuals with an increased (genetic) risk for colorectal cancer. Non-steroidal anti-inflammatory drugs (NSAIDs) have already proven to exert chemopreventive effects. The novel therapeutic drug TRAIL can induce cell death (apoptosis) in transformed cells without affecting normal cells. The subject of this thesis was to investigate the effects of TRAIL and the NSAID sulindac for chemoprevention in models of colorectal adenomas. It was found that the combination of drugs induced more apoptosis than treatment with both single agents. The effect of the combination was dependent on activation of the Wnt-pathway, one of the most important biological pathways in colorectal carcinogenesis. Other potential targets for chemoprevention were also identified.
Last modified: | 13 March 2020 01.13 a.m. |
More news
-
29 November 2023
UMCG opent nieuwe faciliteit voor microbioomonderzoek 
Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...
-
28 November 2023
Science: more exciting than showbiz
Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...
-
13 November 2023
UMCG beantwoordt vragen patiënten met hulp van AI
Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...